NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,217,032 | +27.7% | 2,101,800 | +31.1% | 0.17% | +29.5% |
Q2 2023 | $11,916,234 | +1.2% | 1,603,800 | +148.0% | 0.13% | -39.2% |
Q3 2022 | $11,771,000 | -1.6% | 646,736 | +177.9% | 0.22% | +8.0% |
Q2 2022 | $11,967,000 | +641.4% | 232,693 | +961.8% | 0.20% | +957.9% |
Q1 2022 | $1,614,000 | -99.4% | 21,915 | -98.8% | 0.02% | -99.3% |
Q4 2021 | $252,774,000 | +7779.5% | 1,766,783 | +9884.6% | 2.58% | +3123.8% |
Q1 2021 | $3,208,000 | +21.9% | 17,695 | -25.0% | 0.08% | +95.1% |
Q4 2020 | $2,631,000 | – | 23,596 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |